{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:00:36Z","timestamp":1774990836402,"version":"3.50.1"},"reference-count":298,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.cpcardiol.2009.09.001","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T09:59:56Z","timestamp":1259834396000},"page":"8-64","source":"Crossref","is-referenced-by-count":50,"title":["Device Therapy and Cardiac Transplantation for End-Stage Heart Failure"],"prefix":"10.1016","volume":"35","author":[{"given":"Barry A.","family":"Boilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Raichlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir S.","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2009.09.001_bib1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics, 2009 update","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0733-8651(05)70242-3","article-title":"Epidemiology of heart failure","volume":"19","author":"Miller","year":"2001","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.ATV.0000222012.56447.00","article-title":"Young adults with family history of coronary heart disease have increased arterial vulnerability to metabolic risk factors: the cardiovascular risk in young Finns study","volume":"26","author":"Juonala","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtcvs.2004.04.044","article-title":"Left ventricular assist devices as destination therapy: a new look at survival","volume":"129","author":"Park","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term mechanical left ventricular assistance for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory end stage heart failure","volume":"9","author":"Hershberger","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacc.2008.03.061","article-title":"Heart failure-related hospitalization in the U.S., 1979-2004","volume":"52","author":"Fang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/dis.2006.630","article-title":"The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States","volume":"10","author":"Garrett","year":"2007","journal-title":"Dis Manag"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCHEARTFAILURE.108.782599","article-title":"Mechanical circulatory support registering a therapy in evolution circulation","volume":"1","author":"Kirklin","year":"2008","journal-title":"Heart Fail"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/0003-4975(94)90496-0","article-title":"A surgeon to remember: notes about Vladimir Demikhov","volume":"58","author":"Shumacker","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"suppl 4","key":"10.1016\/j.cpcardiol.2009.09.001_bib11","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.hlc.2008.08.009","article-title":"Review of ECMO (Extra Corporeal Membrane Oxygenation) support in critically ill adult patients","volume":"17","author":"Marasco","year":"2008","journal-title":"Heart Lung Circul"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib12","first-page":"E346","article-title":"Clinical utility of TandemHeart for high-risk tandem procedures: percutaneous balloon aortic valvuloplasty followed by complex PCI","volume":"19","author":"Rajdev","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib13","first-page":"E294","article-title":"High-risk left main coronary stenting supported by percutaneous Impella recover LP 2.5 assist device","volume":"19","author":"Cohen","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2459\/JCM.0b013e3282f9abe7","article-title":"Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study","volume":"9","author":"Burzotta","year":"2008","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.hlc.2008.02.003","article-title":"Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery","volume":"17","author":"Rossiter-Thornton","year":"2008","journal-title":"Heart Lung Circul"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MAT.0b013e31805b8265","article-title":"Prolonged transcutaneous cardiopulmonary support for postcardiotomy cardiogenic shock","volume":"53","author":"Saeed","year":"2007","journal-title":"ASAIO J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jtcvs.2007.01.085","article-title":"Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure","volume":"134","author":"John","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.healun.2008.01.027","article-title":"Bridge to decision using the Levitronix CentriMag short-term ventricular assist device","volume":"27","author":"De Robertis","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/026765910101600103","article-title":"Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure","volume":"16","author":"Dekkers","year":"2001","journal-title":"Perfusion"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1503\/cmaj.1031171","article-title":"Enhanced external counterpulsation in ischemic heart disease and congestive heart failure","volume":"170","author":"Mielniczuk","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jacc.2005.10.079","article-title":"Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure","volume":"48","author":"Feldman","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardfail.2004.10.001","article-title":"Treating heart failure with enhanced external counterpulsation (EECP): design of the prospective evaluation of EECP in heart failure (PEECH) trial","volume":"11","author":"Feldman","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000093192","article-title":"Enhanced external counterpulsation reduces lung\/heart ratio at stress in patients with coronary artery disease","volume":"106","author":"Lee","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1527-5299.2006.05904.x","article-title":"Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial","volume":"12","author":"Abbottsmith","year":"2006","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib27","doi-asserted-by":"crossref","first-page":"II26","DOI":"10.1002\/clc.4960251408","article-title":"Ongoing and planned studies of enhanced external counterpulsation","volume":"25","author":"Conti","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00001573-200403000-00015","article-title":"The role of bridge to transplantation: should LVAD patients be transplanted?","volume":"19","author":"Birks","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trim.2008.10.005","article-title":"Xenotransplantation of solid organs in the pig-to-primate model","volume":"21","author":"Ekser","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib30","first-page":"II83","article-title":"Implantable left ventricular assist device","volume":"90","author":"McCarthy","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1525-1594.2001.025006429.x","article-title":"Implantable total artificial heart developed by Abiomed gets FDA approval for clinical trials","volume":"25","author":"Nose","year":"2001","journal-title":"Artif Organs"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib32","first-page":"1","article-title":"A permanent mechanical auxiliary ventricle: experimental and clinical experience","volume":"9","author":"Kantrowitz","year":"1968","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.107.691972","article-title":"Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection","volume":"116","author":"Lietz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/CIRCULATIONAHA.107.715300","article-title":"Mechanical circulatory support: new data, old problems","volume":"116","author":"Hunt","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.0000139862.48167.23","article-title":"Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)","volume":"110","author":"Stevenson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2007.03.063","article-title":"Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial","volume":"50","author":"Rogers","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.healun.2007.05.012","article-title":"End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices","volume":"26","author":"Radovancevic","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1525-1594.2006.00221.x","article-title":"Living with the Jarvik 2000: a five-plus year experience","volume":"30","author":"Houghton","year":"2006","journal-title":"Artif Organs"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.healun.2006.12.007","article-title":"Does total implantability reduce infection with the use of a left ventricular assist device?","volume":"26","author":"Pae","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2005.07.008","article-title":"Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure","volume":"25","author":"Dang","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib41","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","article-title":"The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates","volume":"51","author":"Matthews","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib42","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jtcvs.2006.11.050","article-title":"Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device","volume":"133","author":"Slaughter","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/MAT.0b013e31817e2b79","article-title":"Improvement in early oxygen uptake kinetics with left ventricular assist device support","volume":"54","author":"Feldman","year":"2008","journal-title":"ASAIO J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices","volume":"83","author":"Etz","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1399-0012.2007.00698.x","article-title":"Quality of life and psychological well-being during and after left ventricular assist device support","volume":"21","author":"Wray","year":"2007","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4037\/ajcc2005.14.2.145","article-title":"The lived experience of spouses of patients with a left ventricular assist device before heart transplantation","volume":"14","author":"Casida","year":"2005","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0193-953X(05)70308-7","article-title":"Psychiatric aspects of cardiovascular disease","volume":"19","author":"Shapiro","year":"1996","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.athoracsur.2007.03.085","article-title":"Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support","volume":"84","author":"Zierer","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jtcvs.2006.09.083","article-title":"Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices","volume":"133","author":"Schulman","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.healun.2003.10.018","article-title":"Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device","volume":"24","author":"Letsou","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib51","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.athoracsur.2008.10.027","article-title":"Platelet dysfunction in outpatients with left ventricular assist devices","volume":"87","author":"Steinlechner","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib53","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jtcvs.2007.12.077","article-title":"Low thromboembolic risk for patients with the Heartmate II left ventricular assist device","volume":"136","author":"John","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.athoracsur.2008.06.030","article-title":"Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy","volume":"86","author":"John","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib55","first-page":"245","article-title":"Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device","volume":"35","author":"Slaughter","year":"2008","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1378\/chest.07-2777","article-title":"Pleural effusion after ventricular assist device placement: prevalence and pleural fluid characteristics","volume":"134","author":"Guha","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib57","first-page":"81","article-title":"Response of the human body to the first permanent implant of the Jarvik-7 total artificial heart","volume":"29","author":"Joyce","year":"1983","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa040186","article-title":"Cardiac replacement with a total artificial heart as a bridge to transplantation","volume":"351","author":"Copeland","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jtcvs.2004.03.052","article-title":"Use of the AbioCor replacement heart as destination therapy for end-stage heart failure with irreversible pulmonary hypertension","volume":"128","author":"Samuels","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jtcvs.2003.07.023","article-title":"Initial experience with the AbioCor implantable replacement heart system","volume":"127","author":"Dowling","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib61","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/eurheartj\/ehn202","article-title":"First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantation","volume":"29","author":"Meyns","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib62","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2004.11.042","article-title":"Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties","volume":"45","author":"Klotz","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib63","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/hc3101.093903","article-title":"Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling","volume":"104","author":"Barbone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib64","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/01.CIR.102.22.2713","article-title":"Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure","volume":"102","author":"Heerdt","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/pcad.2000.7190","article-title":"Left ventricular assist device-induced reverse ventricular remodeling","volume":"43","author":"Burkhoff","year":"2000","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib66","first-page":"198","article-title":"The history and development of cardiac transplantation","volume":"26","author":"DiBardino","year":"1999","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib67","first-page":"243","article-title":"Anastomosis of blood vessels by the patching method and transplantation of the kidney","volume":"74","author":"Carrel","year":"2001","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archsurg.1933.01170020053003","article-title":"Transplantation of the intact mammalian heart","volume":"26","author":"Mann","year":"1933","journal-title":"Arch Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib69","first-page":"299","article-title":"Auto-transplantation of the canine heart","volume":"115","author":"Willman","year":"1962","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib70","first-page":"1271","article-title":"The operation","volume":"41","author":"Barnard","year":"1967","journal-title":"S Afr Med J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0025-6196(12)60399-1","article-title":"The development of cardiac transplantation","volume":"67","author":"Rodeheffer","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib72","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.healun.2007.06.004","article-title":"Registry of the international society for heart and lung transplantation","volume":"26","author":"Taylor","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib73","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the international society for heart and lung transplantation","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib74","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jacc.2007.04.099","article-title":"Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network\/U.S. United Network of Organ Sharing data, 1990-2005","volume":"50","author":"Lietz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib75","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib76","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1053-2498(99)00024-8","article-title":"An analysis of the effect of age on survival after heart transplant","volume":"18","author":"Borkon","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib77","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0003-4975(03)01070-1","article-title":"Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis","volume":"76","author":"Morgan","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib78","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","article-title":"Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era","volume":"84","author":"Nwakanma","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib79","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00746.x","article-title":"Practical application of the virtual crossmatch","volume":"11","author":"Zangwill","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib80","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1053-2498(01)00422-3","article-title":"Panel-reactive antibody screening practices prior to heart transplantation","volume":"21","author":"Betkowski","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib81","first-page":"194","article-title":"Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation","volume":"13","author":"Loh","year":"1994","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib82","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.2006.00509.x","article-title":"Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin","volume":"20","author":"Leech","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib83","first-page":"921","article-title":"Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation","volume":"10","author":"Lavee","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib84","series-title":"Standards for histocompatibility testing","author":"Lenexa","year":"1998"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib85","unstructured":"UNOS. The United Network for Organ Sharing. Standards for histocompatibility testing. 1998. ByLaws Appendix B Attachment JJA, www.unos.org\/policiesandbylaws\/bylaws."},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib86","first-page":"265","article-title":"Transplantation of the heart","volume":"2","author":"Shumway","year":"1966","journal-title":"Adv Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib87","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0735-1097(10)80330-4","article-title":"Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities","volume":"16","author":"Jacquet","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib88","first-page":"331","article-title":"Anatomic characteristics and valvular function of the transplanted heart: transthoracic versus transesophageal echocardiographic findings","volume":"9","author":"Angermann","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib89","series-title":"The Expanding Role of Cardiac Transplantation","author":"Banner","year":"1989"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib90","first-page":"1","article-title":"Recent Development in Lung and Heart-Lung Transplantation","volume":"vol 3","author":"Yacoub","year":"1989"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib91","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0003-4975(99)00796-1","article-title":"Orthotopic cardiac transplantation technique: a survey of current practice","volume":"68","author":"Aziz","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib92","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0003-4975(91)91311-I","article-title":"Total orthotopic heart transplantation: an alternative to the standard technique","volume":"52","author":"Drefus","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1013934","article-title":"An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium","volume":"39","author":"Sievers","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jtcvs.2007.05.037","article-title":"Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis","volume":"134","author":"Schnoor","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.healun.2007.01.002","article-title":"Induction therapy in heart transplantation: is there a role?","volume":"26","author":"Uber","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 1","key":"10.1016\/j.cpcardiol.2009.09.001_bib96","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1111\/j.1432-2277.1994.tb01390.x","article-title":"Non-Hodgkin's lymphoma after kidney or heart transplantation: frequency of occurrence during the first posttransplant year","volume":"7","author":"Opelz","year":"1994","journal-title":"Transpl Int"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib97","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib98","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2004.01.002","article-title":"To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?","volume":"24","author":"Higgins","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib99","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.healun.2007.08.010","article-title":"Influence of induction therapy, immunosuppressive regimen and antiviral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry","volume":"26","author":"Crespo-Leiro","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib100","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.tp.0000209924.00229.e5","article-title":"A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study","volume":"81","author":"Segovia","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib101","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2004.09.010","article-title":"A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation","volume":"24","author":"Mehra","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib102","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa032953","article-title":"Daclizumab to prevent rejection after cardiac transplantation","volume":"352","author":"Hershberger","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib103","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib105","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007890-200111270-00015","article-title":"Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS\/ISHLT Thoracic Registry","volume":"72","author":"Hosenpud","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib107","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/01.tp.0000186383.22264.b3","article-title":"Review of major clinical trials with mycophenolate mofetil in cardiac transplantation","volume":"80","author":"Kobashigawa","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1053-2498(03)00097-4","article-title":"Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia","volume":"23","author":"Pethig","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib109","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0041-1345(02)03092-0","article-title":"Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients","volume":"34","author":"Lietz","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib110","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S1053-2498(02)00440-0","article-title":"Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients","volume":"21","author":"Weigel","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib111","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib112","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00063030-200721030-00001","article-title":"Tacrolimus in heart transplant recipients: an overview","volume":"21","author":"Patel","year":"2007","journal-title":"Biodrugs"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib113","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.transproceed.2006.08.191","article-title":"Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen","volume":"38","author":"Aguero","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.144.1.251","article-title":"Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin","volume":"144","author":"Dumont","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib115","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.1041540103","article-title":"Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle","volume":"154","author":"Terada","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/16.suppl_1.121","article-title":"Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation","volume":"16","author":"Morales","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib118","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1523-1755.2004.00498.x","article-title":"Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity","volume":"65","author":"Shihab","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib119","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib121","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib122","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm1729","article-title":"Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart","volume":"14","author":"Hauck","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib124","first-page":"540","article-title":"Cardiovascular research in Australia","volume":"16","author":"Doggrell","year":"2003","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib126","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/01.tp.0000290686.68910.bd","article-title":"A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus","volume":"84","author":"Hill","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib127","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejcts.2003.11.030","article-title":"Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients","volume":"25","author":"Groetzner","year":"2004","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1399-0012.2007.00668.x","article-title":"Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients","volume":"21","author":"Knight","year":"2007","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib131","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib132","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib133","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000072016.13090.4E","article-title":"Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study","volume":"76","author":"Troppmann","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib134","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1053-2498(02)00472-2","article-title":"Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease","volume":"22","author":"Michaels","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1053-2498(03)00189-X","article-title":"Does acute cellular rejection correlate with cardiac allograft vasculopathy?","volume":"23","author":"Yamani","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib136","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib137","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.healun.2006.10.002","article-title":"Molecular testing in the management of cardiac transplant recipients: initial clinical experience","volume":"25","author":"Starling","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib138","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.healun.2007.05.017","article-title":"Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the invasive monitoring attenuation through gene expression (IMAGE) trial","volume":"26","author":"Pham","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib139","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1053-2498(00)00095-4","article-title":"Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection","volume":"19","author":"Taylor","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib140","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1600-6143.2007.01900.x","article-title":"Acute antibody-mediated rejection following heart transplantation","volume":"7","author":"Uber","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib141","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.5858\/2007-131-1169-UOCTP","article-title":"Update on cardiac transplantation pathology","volume":"131","author":"Tan","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib142","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.healun.2004.07.021","article-title":"C4d deposition in cardiac allografts correlates with alloantibody","volume":"24","author":"Smith","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib143","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.tp.0000278094.41131.9f","article-title":"The changing pattern of humoral rejection in cardiac transplant recipients","volume":"84","author":"Almuti","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib144","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1540-8159.1994.tb03798.x","article-title":"A comparison of VVIR and DDDR pacing following cardiac transplantation","volume":"17","author":"Roelke","year":"1994","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up","volume":"26","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib146","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1053-2498(02)00498-9","article-title":"The registry of the international society for heart and lung transplantation: nineteenth official report-2002","volume":"21","author":"Hertz","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib147","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1053-2498(99)00128-X","article-title":"Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging","volume":"19","author":"Kapadia","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib148","first-page":"233","article-title":"Stem cells and transplant vasculopathy","volume":"57","author":"Boilson","year":"2009","journal-title":"Minerra Cardioangiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib149","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/j.1600-6143.2007.01930.x","article-title":"Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness","volume":"7","author":"Kuppahally","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1053-2498(03)00210-9","article-title":"First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation","volume":"22","author":"Kobashigawa","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib151","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","article-title":"Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression","volume":"4","author":"Caforio","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib152","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.CIR.85.4.1433","article-title":"Cardiac growth after pediatric heart transplantation","volume":"85","author":"Bernstein","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib153","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00637.x","article-title":"Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model","volume":"134","author":"Adams","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib154","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","article-title":"Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study","volume":"20","author":"Jimenez","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00007890-199802270-00015","article-title":"Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease","volume":"65","author":"Brunner-La Rocca","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.healun.2009.01.006","article-title":"Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation","volume":"28","author":"Raichlin","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0041-1345(96)00013-9","article-title":"Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients","volume":"29","author":"Opelz","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib158","first-page":"418","article-title":"Acute rejection and coronary artery disease in long-term survivors of heart transplantation","volume":"8","author":"Narrod","year":"1989","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib159","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0195-668X(03)00237-9","article-title":"Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy","volume":"24","author":"Vassalli","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib160","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)01714-X","article-title":"Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome","volume":"39","author":"Yamani","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib161","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2005.11.449","article-title":"The cumulative effect of acute rejection on development of cardiac allograft vasculopathy","volume":"25","author":"Stoica","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib162","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0735-1097(03)00645-4","article-title":"Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients","volume":"42","author":"Hognestad","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib163","doi-asserted-by":"crossref","first-page":"III233","DOI":"10.1161\/01.CIR.102.suppl_3.III-233","article-title":"Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction","volume":"102","author":"Pethig","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib164","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/TP.0b013e3181684319","article-title":"Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients","volume":"85","author":"Raichlin","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.healun.2007.05.008","article-title":"Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy","volume":"26","author":"Raichlin","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib166","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib167","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.amjcard.2008.12.039","article-title":"Features of cardiac allograft coronary endothelial dysfunction","volume":"103","author":"Raichlin","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib168","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1161\/hc5001.100796","article-title":"Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death","volume":"104","author":"Hollenberg","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib169","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.93.3.457","article-title":"Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant","volume":"93","author":"Davis","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib170","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/01.CIR.90.6.3018","article-title":"Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries","volume":"90","author":"Sudhir","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib171","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4899-0987-9_20","article-title":"Proximal signals and the control of S-phase entry in interleukin-2-stimulated T lymphocytes","volume":"365","author":"Abraham","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib172","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0002-9149(91)90545-V","article-title":"Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation","volume":"67","author":"Edwards","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib173","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.23.6.957","article-title":"Cyclosporine produces endothelial dysfunction by increased production of superoxide","volume":"23","author":"Diederich","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib174","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1681\/ASN.V281291","article-title":"Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat","volume":"2","author":"Diederich","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib175","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.261.24.3607","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation","volume":"261","author":"Rubin","year":"1989","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib176","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00335972","article-title":"Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients","volume":"6","author":"Koskinen","year":"1993","journal-title":"Transpl Int"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib177","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83-121.2000","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib178","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.106.627570","article-title":"Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children","volume":"115","author":"Hussain","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib179","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.TP.0000119722.37337.DC","article-title":"Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients","volume":"77","author":"Bonaros","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib180","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.transproceed.2007.09.013","article-title":"The influence of cytomegalovirus infection, confirmed by pp65 Antigen presence, on the development of cardiac allograft vasculopathy","volume":"39","author":"Zakliczynski","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib181","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can J Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib182","first-page":"IV269","article-title":"Progressive coronary luminal narrowing after cardiac transplantation","volume":"82","author":"Gao","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib183","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00007890-200003150-00030","article-title":"Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation","volume":"69","author":"Julius","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib184","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0735-1097(94)00323-I","article-title":"Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound","volume":"25","author":"Rickenbacher","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib185","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0002-9149(98)00645-6","article-title":"Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts","volume":"82","author":"Kushwaha","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib186","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.TP.0000071200.37399.1D","article-title":"Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy","volume":"76","author":"Sharples","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib187","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9149(99)80131-3","article-title":"Intraindividual variability of cardiac allograft vasculopathy as assessed by intravascular ultrasound","volume":"76","author":"Klauss","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib188","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.tp.0000195774.26382.34","article-title":"Development of malignancy following lung transplantation","volume":"81","author":"Amital","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib189","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jtcvs.2004.09.031","article-title":"Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation","volume":"129","author":"Fedak","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib190","first-page":"620","article-title":"Canadian Cardiovascular Society Consensus Conference on Cardiac Transplantation","volume":"19","author":"Ross","year":"2003","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib191","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/01.CIR.0000035654.18341.5E","article-title":"Coronary plaque classification with intravascular ultrasound radiofrequency data analysis","volume":"106","author":"Nair","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib192","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0301-5629(01)00436-7","article-title":"Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data","volume":"27","author":"Nair","year":"2001","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib193","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2006.02.044","article-title":"Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology","volume":"47","author":"Nasu","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib194","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jacc.2008.12.041","article-title":"Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression","volume":"53","author":"Raichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ki.1996.74","article-title":"Chronic renal allograft rejection: immunologic and nonimmunologic risk factors","volume":"49","author":"Massy","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib196","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/lt.20081","article-title":"Arteriopathy in chronic allograft rejection in liver transplantation","volume":"10","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib197","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.1996.tb15292.x","article-title":"Endothelin receptors in human coronary artery and aorta","volume":"117","author":"Bacon","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib198","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11936-001-0085-7","article-title":"Transplant coronary vasculopathy","volume":"3","author":"Pamboukian","year":"2001","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib199","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-6143.2005.01138.x","article-title":"Impaired left ventricular systolic function early after heart transplantation is associated with cardiac allograft vasculopathy","volume":"6","author":"Bolad","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib200","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2004.02.045","article-title":"Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience","volume":"43","author":"Benza","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib201","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2006.01.081","article-title":"In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease","volume":"48","author":"Jonas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","article-title":"Simvastatin initiated early after heart transplantation: 8-year prospective experience","volume":"107","author":"Wenke","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib204","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9149(99)80432-9","article-title":"An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy","volume":"75","author":"Mehra","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199301213280303","article-title":"A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients","volume":"328","author":"Schroeder","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib206","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(02)08154-0","article-title":"Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial","volume":"359","author":"Fang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib207","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biopha.2006.09.017","article-title":"Atorvastatin attenuates transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation","volume":"61","author":"Shirakawa","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib208","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a trial of pravastatin in heart transplant recipients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib209","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.hfc.2007.02.007","article-title":"Cardiac allograft vasculopathy: an update","volume":"3","author":"Sipahi","year":"2007","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib210","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1517\/14656566.7.17.2369","article-title":"Treatment of allograft vasculopathy in heart transplantation","volume":"7","author":"Segovia","year":"2006","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib211","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.healun.2006.12.003","article-title":"Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation","volume":"26","author":"Lubitz","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib212","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib213","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.107.737965","article-title":"Sirolimus and cardiac transplantation: is it the \u201cmagic bullet\u201d?","volume":"116","author":"Mudge","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib214","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib215","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/eurheartj\/ehp123","article-title":"Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared to calcineurin-inhibitors in stable cardiac transplant recipients","volume":"30","author":"Raichlin","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib216","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib217","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jacc.2008.12.041","article-title":"Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression","volume":"53","author":"Raichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib218","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healun.2004.11.005","article-title":"Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience","volume":"24","author":"Lobach","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib219","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1034\/j.1600-0560.2002.291009.x","article-title":"Cutaneous lesions showing giant yeast forms of Blastomyces dermatitidis","volume":"29","author":"Walker","year":"2002","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib220","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1053-2498(02)00817-3","article-title":"Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient","volume":"22","author":"Masri","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib221","first-page":"37","article-title":"Lower respiratory tract infections in patients during hospital stay after heart transplantation","volume":"8","author":"Jastrzebski","year":"2003","journal-title":"Ann Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib222","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0195-6701(03)00134-8","article-title":"Infection control measures for adult cardiac surgery in the UK\u2014a survey of current practice","volume":"54","author":"Kendall","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib223","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1010-7940(00)00469-3","article-title":"Evolution of antimicrobial prophylaxis in cardiovascular surgery","volume":"18","author":"Kriaras","year":"2000","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib224","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.70.6.585","article-title":"Antibiotic prophylaxis for cardiac surgery: current United Kingdom practice","volume":"70","author":"Parry","year":"1993","journal-title":"Br Heart J"},{"issue":"suppl B","key":"10.1016\/j.cpcardiol.2009.09.001_bib225","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0195-6701(98)90199-2","article-title":"The nose: an underestimated source of Staphylococcus aureus causing wound infection","volume":"40","author":"Casewell","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib226","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0003-4975(01)02519-X","article-title":"Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics","volume":"71","author":"Cimochowski","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib227","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000230459.22968.26","article-title":"Benefits of cytomegalovirus prophylaxis in solid organ transplantation","volume":"82","author":"Pescovitz","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib228","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib229","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199856010-00012","article-title":"Ganciclovir","volume":"56","author":"Noble","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib230","first-page":"656","article-title":"Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation","volume":"10","author":"Cooper","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib231","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00007890-199803150-00007","article-title":"Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis","volume":"65","author":"Couchoud","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib232","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir Res"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib233","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1399-0012.1998.tb01103.x","article-title":"Maintenance therapy with oral ganciclovir after treatment of cytomegalovirus infection","volume":"12","author":"Nankivell","year":"1998","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib234","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised Trial of Efficacy and Safety of Oral Ganciclovir in the Prevention of Cytomegalovirus Disease in Liver-Transplant Recipients","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib235","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2003.08.034","article-title":"Preemptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation","volume":"23","author":"Devyatko","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib236","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00007890-199808150-00008","article-title":"Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood","volume":"66","author":"Baldanti","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib237","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1600-6143.2001.10403.x","article-title":"(CMV) resistance to antivirals","volume":"1","author":"Drew","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib238","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib239","first-page":"77","article-title":"Management of CMV infection and disease in transplant patients","volume":"11","author":"Razonable","year":"2004","journal-title":"Herpes"},{"issue":"suppl 1","key":"10.1016\/j.cpcardiol.2009.09.001_bib240","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1086\/342965","article-title":"Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation","volume":"186","author":"Fiddian","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib241","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.healun.2006.08.001","article-title":"Is toxoplasmosis prophylaxis necessary in cardiac transplantation?","volume":"25","author":"Baran","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib242","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib243","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0163-4453(94)91082-0","article-title":"Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years","volume":"29","author":"Orr","year":"1994","journal-title":"J Infect"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib244","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004920","article-title":"Antifungal agents for preventing fungal infections in solid organ transplant recipients","author":"Playford","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib245","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199012203232510","article-title":"Cancers complicating organ transplantation","volume":"323","author":"Penn","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib246","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007890-199601270-00019","article-title":"Malignant melanoma in organ allograft recipients","volume":"61","author":"Penn","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib247","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMe058018","article-title":"Immunosuppressive drugs and the risk of cancer after organ transplantation","volume":"352","author":"Dantal","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib248","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib249","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0936-6555(98)80069-1","article-title":"Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?","volume":"10","author":"Veness","year":"1998","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib250","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F","article-title":"Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience","volume":"85","author":"Veness","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib251","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.cpcardiol.2009.09.001_bib252","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1111\/j.1432-2277.2000.tb02065.x","article-title":"Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?","volume":"13","author":"Gjersvik","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib253","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.mlg.0000205170.24517.28","article-title":"Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine A in carcinogenesis","volume":"116","author":"Tiu","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib254","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib255","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0041-1345(03)00351-8","article-title":"Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib256","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1399-0012.2004.00188.x","article-title":"Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies","volume":"18","author":"Mathew","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib257","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1524-4725.2005.31038","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy","volume":"31","author":"Otley","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib258","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib259","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2007.08203.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks","volume":"157","author":"Otley","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib260","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2230.2006.02098.x","article-title":"Skin-cancer awareness in Scottish cardiac transplant recipients","volume":"31","author":"Tavadia","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib261","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib262","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1053-2498(02)00456-4","article-title":"Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation","volume":"21","author":"McNamara","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib263","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/0003-4975(95)00782-2","article-title":"Novo solid malignancies after cardiac transplantation","volume":"60","author":"Goldstein","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib264","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0003-4975(95)00120-4","article-title":"Solid tumors after heart transplantation: lethality of lung cancer","volume":"60","author":"Pham","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0889-8588(18)30250-8","article-title":"Tumors after renal and cardiac transplantation","volume":"7","author":"Penn","year":"1993","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib266","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib267","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib268","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2559.2007.02870.x","article-title":"Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders","volume":"51","author":"Borenstein","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib269","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000478-200403000-00018","article-title":"Anaplastic large cell lymphoma associated with Epstein\u2013Barr virus following cardiac transplant","volume":"28","author":"Pitman","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.dad.0000154414.46851.18","article-title":"Primary \u201ccutaneous\u201d T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review","volume":"27","author":"Salama","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib271","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/10428190500254505","article-title":"Development of hairy cell leukemia in a patient after cardiac transplantation","volume":"47","author":"Tsao","year":"2006","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib272","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/modpathol.3800040","article-title":"EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation","volume":"17","author":"Tsao","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib273","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib274","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.TP.0000085602.22498.CF","article-title":"Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per SE?","volume":"76","author":"Birkeland","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib275","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":"Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University","volume":"22","author":"Gao","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib276","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/01.TP.0000144333.19106.58","article-title":"Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry","volume":"78","author":"Aull","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib277","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","article-title":"Posttransplant lymphoproliferative disorders not associated with Epstein\u2013Barr virus: a distinct entity?","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib278","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00007890-200003150-00027","article-title":"Epstein\u2013Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant","volume":"69","author":"Dotti","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib279","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.tp.0000265914.16491.7d","article-title":"Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein\u2013Barr virus infection than younger renal transplant recipients","volume":"83","author":"Smith","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","article-title":"Identifying the patient at risk for post-transplant lymphoproliferative disorder","volume":"3","author":"Cockfield","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib281","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/00007890-199709270-00010","article-title":"Reduced incidence of Epstein\u2013Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy","volume":"64","author":"Darenkov","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib282","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.1995.tb00297.x","article-title":"Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder","volume":"9","author":"Davis","year":"1995","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib283","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/166.5.986","article-title":"Quantitative oropharyngeal Epstein\u2013Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder","volume":"166","author":"Preiksaitis","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib284","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.transproceed.2005.01.034","article-title":"Primary cardiac lymphoma in a heart transplant recipient","volume":"37","author":"Nart","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib285","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/je.1998.v11.a90473","article-title":"Lymphoproliferative disease seen as a cardiac mass after orthotopic heart transplantation","volume":"11","author":"Ouseph","year":"1998","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib286","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.0303-6987.2005.00332.x","article-title":"Subcutaneous panniculitic T-cell lymphoma in a cardiac allograft recipient","volume":"32","author":"Bregman","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib287","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0303-6987.2004.00197.x","article-title":"Post-transplant lymphoproliferative disorder limited to the skin","volume":"31","author":"Samolitis","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib288","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1054-8807(02)00126-6","article-title":"Isolated pleural PTLD after cardiac transplantation","volume":"11","author":"Lamba","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib289","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1600-051X.2004.00537.x","article-title":"Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin","volume":"31","author":"Rolland","year":"2004","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib290","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2008.05.024","article-title":"Late allograft failure after heart transplantation: 2 unusual cases","volume":"27","author":"Boilson","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib291","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0339(199712)17:6<429::AID-DC10>3.0.CO;2-O","article-title":"Role of fine-needle aspiration in clinical management of transplant patients","volume":"17","author":"Siddiqui","year":"1997","journal-title":"Diagn Cytopathol"},{"issue":"suppl 1","key":"10.1016\/j.cpcardiol.2009.09.001_bib292","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008372814223","article-title":"Humanized anti-CD20 monoclonal antibody (rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib293","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","article-title":"Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)","volume":"5","author":"Oertel","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib294","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1345\/aph.1G706","article-title":"Posttransplant lymphoproliferative disorder","volume":"41","author":"Everly","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib295","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1182\/blood.V97.6.1590","article-title":"Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial","volume":"97","author":"Haddad","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib296","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.tp.0000258647.50947.78","article-title":"Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab","volume":"83","author":"Trappe","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib297","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/424447","article-title":"New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients","volume":"39","author":"Preiksaitis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cpcardiol.2009.09.001_bib298","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280609001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280609001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:07:39Z","timestamp":1739462859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280609001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":298,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0146280609001248"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2009.09.001","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}